Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Diabetes Complications. 2018 Oct 4;32(12):1160–1168. doi: 10.1016/j.jdiacomp.2018.09.018

Table 2a:

Unadjusted and sequentially adjusted results of logistic regression models representing the odds ratio (OR) associated with moderate-risk versus low-risk albuminuria in youth with type 1 diabetes (n=1,136)a

Covariates Unadjusted Model 1** Model 2** Model 3** Model 4**
OR (95%
CI)
p-value OR
(95%
CI)
p-
value
OR (95%
CI)
p-
value
OR (95%
CI)
p-
value
OR
(95% CI)
p-
value
Age at Diagnosis
(5.0-year increase)
1.0 (0.8,
1.3)
1.0 1.0 (0.8,
1.3)
1.0 0.9 (0.6,
1.2)
0.4 0.8 (0.5,
1.1)
0.1 0.8 (0.5,
1.1)
0.1
Sex (Female vs
Male)
0.9 (0.6,
1.4)
0.7 0.9 (0.6,
1.4)
0.6 1.0 (0.6,
1.5)
0.8 1.0 (0.7,
1.7)
0.8 1.0 (0.6,
1.7)
0.9
Raceb (AA vs Other) 2.2 (1.2,
4.2)
0.02 2.2 (1.1,
4.1)
0.02 1.5 (0.7,
3.2)
0.3 1.4 (0.6,
3.1)
0.4 1.4 (0.6,
3.1)
0.4
Diabetes durationc
(1-year increase)
1.0 (0.9,
1.2)
0.5 1.0 (0.9,
1.2)
0.5 1.0 (0.9,
1.1)
1.0 1.0 (0.9,
1.1)
0.7 1.0 (0.9,
1.1)
0.7
BMI-Z (AUC)
(1-unit increase)
0.8 (0.6,
1.0)
0.02 -- -- 0.8 (0.6,
1.0)
0.05 0.8 (0.6,
1.0)
0.04 0.8 (0.6,
1.0)
0.1
HbA1c (AUC)
(1-percent increase)
1.5 (1.3,
1.7)
<0.0001 -- -- 1.4 (1.2,
1.7)
0.0001 1.4 (1.1,
1.6)
0.001 1.3 (1.1,
1.6)
0.002
Triglyceridesd
(AUC)
(1-log unit increase)
1.7 (1.1,
2.8)
0.03 -- -- 1.6 (0.9,
2.7)
0.1 1.5 (0.9,
2.6)
0.2 1.5 (0.9,
2.7)
0.2
Smoking Statuse at
Follow-up
1.8 (1.1,
3.1)
0.03 -- -- -- -- 1.5 (0.8,
2.9)
0.2 1.6 (0.8,
3.0)
0.2
Health Insurance at
Follow-up (None vs
Insured)
3.5 (1.6,
7.4)
0.001 -- -- -- -- 2.7 (1.1,
6.5)
0.02 2.7 (1.1,
6.5)
0.03
Baseline UACRd
(1-log unit increase)
1.2 (1.0,
1.5)
0.07 -- -- -- -- -- -- 1.2 (1.0,
1.5)
0.1
eGFRBouvet at
Follow-up (10 unit
increase)f
1.1 (1.0,
1.2)
0.04 -- -- -- -- -- -- 1.0 (0.9,
1.1)
0.9
LDL (AUC)
(10-unit increase)
1.0 (0.9,
1.1)
1.0 -- -- -- -- -- -- -- --
HDL (AUC)
(10-unit increase)
0.9 (0.8,
1.1)
0.5 -- -- -- -- -- -- -- --
SBP-Z (AUC)
(1-mmHg increase)
1.1 (0.8,
1.4)
0.5 -- -- -- -- -- -- -- --
Waist:Height ratio
(AUC)
(0.1-unit increase)
0.9 (0.6,
1.3)
0.6 -- -- -- -- -- -- -- --
Length of Follow-up
(1.0-year increase)
1.1 (0.9,
1.2)
0.4 -- -- -- -- -- -- -- --
Insulin Sensitivity
Scoref (AUC) (1-unit
decrease)
1.1 (1.0,
1.2)
0.07 -- -- -- -- -- -- -- --
a

Albuminuria categories were classified based on urine albumin-to-creatinine ratio (UACR) measures at baseline and UACR at follow-up visit (see Figure 2 for definitions). Moderate-risk albuminuria included albuminuria progression and persistently high albuminuria. Low-risk albuminuria included albuminuria regression and persistently normoalbuminuria.

b

African American race includes Hispanic and Non-Hispanic ethnicity.

c

Diabetes duration measured at follow-up visit.

d

Triglycerides and UACR were transformed using natural log scale.

e

Smoking status defined at follow-up status as Current vs Former/Never.

f

Insulin Sensitivity Score is derived from HbA1c, waist circumference and triglycerides: IS=exp[4.64725−(0.02032×waist,cm)−(0.09779×HbA1c,%)−(0.002350×triglyceride,mg/dl)

Abbreviations: AUC= Area under the curve (baseline to follow-up visit). BMI=body mass index; UACR=urine albumin:creatinine ratio; LDL=low density lipoprotein; HDL=high density lipoprotein; SBP=systolic blood pressure; eGFR = estimated glomerular filtration rate.

**

Adjusted models in Type 1 Diabetes:

Model 1 (non-modifiable characteristics): age at diagnosis, sex, race, diabetes duration

Model 2 (modifiable clinical characteristics): Model 1 + HbA1c, BMI-Z, TG

Model 3 (modifiable social characteristics): Model 2 + follow-up smoking status, follow-up health insurance status

Model 4 (baseline UACR): Model 3 + baseline UACR measure and follow-up eGFR